老虎证券

BUZZ-Australia's Neurizon Therapeutics jumps after US FDA clears ALS product for trial use

Reuters
2025/12/11
BUZZ-Australia's <a href="https://laohu8.com/S/PAAFF">Neurizon Therapeutics</a> jumps after US FDA clears ALS product for trial use

** Shares of Australia's Neurizon Therapeutics NUZ.AX jump as much as 8.7% to A$0.125, their highest since November 20

** Neurodegenerative disease-focused biotech co says the U.S. Food and Drug Administration has cleared the use of its "NUZ001 regimen" in the HEALEY ALS platform trial

** NUZ-001 is a potential treatment option for people living with amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disorder

** YTD, shares down 32.4%

(Reporting by Shruti Agarwal in Bengaluru)

((Shruti.Agarwal@thomsonreuters.com))

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10